A survey of leading North American neonatal intensive care units reveals striking variation in how clinicians diagnose and ...

A national survey of 422 neonatologists and cardiologists reveals deep disagreement over which echocardiographic markers ...

Closing patent ductus arteriosus (PDA) is a widely accepted approach in the management of very low birth weight (VLBW) infants. Our objective is to test the hypothesis that conservative management (no ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement that provides best-practice guidance for the treatment of patent ductus arteriosus (PDA) using ...

Newswise — A patent ductus arteriosus (PDA) is a common condition in premature babies. But when should a PDA be treated—and when will it close on its own? Finding that answer is often not a simple ...

The US Food and Drug Administration has cleared the smallest occlusion device to date for the treatment of symptomatic patent ductus arteriosus (PDA) in premature infants, device manufacturer Abbott ...

Cyclo-oxygenase inhibitors like Indomethacin or Ibuprofen are used to close the PDA during the 2nd week of life. 1) INDOMETHACIN Indomethacin is a non-steroidal anti-inflammatory medication. It ...

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...

Patent ductus arteriosus (PDA), one of the more common cardiac defects present at birth, is the persistence of an opening between the pulmonary artery and aorta. This opening is as a result of failure ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus ...

Doctors in Mumbai have successfully treated a premature baby weighing just for a patent ductus arteriosus (PDA), a critical ...